Jay Lin

发表

Increasing prevalence of atrial fibrillation and flutter in the United States.

G. Naccarelli, H. Varker, Jay Lin, 2009, The American journal of cardiology.

Does Device Make Any Difference? A Real-world Retrospective Study of Insulin Treatment Among Elderly Patients With Type 2 Diabetes

O. Baser, Jay Lin, Wenhui Wei, 2014, Journal of diabetes science and technology.

Lixisenatide Treatment for Older Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetics: Meta-Analysis of Five Randomized Controlled Trials

M. Hanefeld, R. Berria, R. Aronson, 2014, Advances in Therapy.

Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral

R. Baker, Jay Lin, S. Offord, 2013, Journal of medical economics.

Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States

A. Amin, J. Trocio, Jay Lin, 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes

D. Battleman, Jay Lin, S. Deitelzweig, 2010, Advances in therapy.

Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants

G. Fermann, Jay Lin, S. Deitelzweig, 2020, Journal of medical economics.

Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States

C. Russ, A. Nadkarni, O. Dina, 2018, Advances in Therapy.

Impact of Oral Antipsychotic Medication Adherence on Healthcare Resource Utilization Among Schizophrenia Patients with Medicare Coverage

R. Baker, Jay Lin, S. Offord, 2013, Community Mental Health Journal.

Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter

M. Jhaveri, Jay Lin, A. Koren, 2014, Advances in Therapy.

Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States

A. Amin, Jay Lin, S. Thompson, 2013, BMC Neurology.

Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease.

P. Higgins, M. Skup, J. Chao, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Impact of earlier versus later monitoring on disease progression and healthcare costs among patients with chronic myeloid leukemia in the United States

E. Jabbour, Jay Lin, L. Siegartel, 2018, Leukemia & lymphoma.

Venous thromboembolism in the US: does race matter?

Jay Lin, K. Schulman, S. Deitelzweig, 2011, Journal of Thrombosis and Thrombolysis.

Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis

A. Amin, G. Lenhart, Jay Lin, 2009, Thrombosis and Haemostasis.

Predictors of outcomes in patients with type 2 diabetes in the lixisenatide GetGoal clinical trials

L. Blonde, R. Goldenberg, T. Dex, 2016, Diabetes, obesity & metabolism.

Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US

T. Fan, Jay Lin, M. Lingohr-Smith, 2016, ClinicoEconomics and outcomes research : CEOR.

Heparin-induced thrombocytopenia (HIT): Clinical and economic outcomes

S. Goldhaber, S. Baroletti, Jay Lin, 2008, Thrombosis and Haemostasis.

Need to improve thromboprophylaxis across the continuum of care for surgical patients

A. Amin, Jay Lin, A. Ryan, 2010, Advances in therapy.

Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study

D. Battleman, Jay Lin, A. Spyropoulos, 2009, Journal of Thrombosis and Thrombolysis.

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA

B. Seal, Jay Lin, A. Aly, 2021, Hepatic oncology.

Improving quality of care in oncology through healthcare payment reform.

S. Ramsey, Jay Lin, M. Lingohr-Smith, 2018, The American journal of managed care.

Real-world treatment pattern and outcomes among patients who took tapentadol IR or oxycodone IR

M. Rupnow, Jay Lin, Myoung S. Kim, 2013, Journal of medical economics.

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA

A. Amin, Jay Lin, M. Lingohr-Smith, 2019, Drugs in context.

Use of drospirenone/ethinyl estradiol (DRSP/EE) among women with acne reduces acne treatment-related resources

V. Joish, Jay Lin, A. Schmidt, 2011, Journal of medical economics.

Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials.

P. de Pablos-Velasco, D. Yabe, M. Evans, 2016, Journal of diabetes and its complications.

Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy

P. Home, M. Riddle, Jay Lin, 2012, Obstetrics and gynecology international.

Evaluating Costs of Biologic Drugs for the Treatment of Moderate-to-Severe Psoriasis in the United States

M. Lebwohl, S. Feldman, A. Armstrong, 2019, Journal of Psoriasis and Psoriatic Arthritis.

Economic impact of enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in patients with acute ischemic stroke: a hospital perspective of the PREVAIL trial.

L. Annemans, G. Pineo, Jay Lin, 2012, Journal of hospital medicine.

Real-World Rates of In-hospital and Postdischarge Deep-Vein Thrombosis and Pulmonary Embolism in At-Risk Medical Patients in the United States

A. Amin, Jay Lin, S. Thompson, 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Lack of Thromboprophylaxis Across the Care Continuum in US Medical Patients

A. Amin, Jay Lin, A. Ryan, 2010, Hospital practice.

Comparison of inpatient admission rates of patients treated with apixaban vs. warfarin for venous thromboembolism in the emergency department

C. Russ, P. Hlavacek, Jay Lin, 2020, Hospital practice.

Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States

A. Amin, J. Trocio, Jay Lin, 2015, Journal of managed care & specialty pharmacy.

Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients

A. Amin, J. Trocio, Jay Lin, 2014, Journal of medical economics.

Lixisenatide reduces glycaemic variability in insulin‐treated patients with type 2 diabetes

B. Kovatchev, E. Renard, D. O'Neal, 2017, Diabetes, obesity & metabolism.

Preventing venous thromboembolism in US hospitals: Are surgical patients receiving appropriate prophylaxis?

A. Amin, Guiping Yang, S. Stemkowski, 2008, Thrombosis and Haemostasis.

Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome.

Jay Lin, S. Boccuzzi, A. L. Feliu, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results

A. Amin, J. Trocio, Jay Lin, 2015, Journal of Thrombosis and Thrombolysis.

HOSPITAL READMISSION AND ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM: FROM A HEALTH PLAN PERSPECTIVE

Jay Lin, A. Spyropoulos, 2006 .

Preventing Venous Thromboembolism Following Orthopedic Surgery in the United States

Jay Lin, S. Deitelzweig, G. Lin, 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States

A. Nadkarni, P. Hlavacek, Jay Lin, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Impact of Genetic Mutations and Health Plan Access to Therapies on Treatment Response and Drug Costs Related to Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myelogenous Leukemia

E. Jabbour, Jay Lin, Dinara Makenbaeva, 2015, American journal of clinical oncology.

Improving Type 2 Diabetes Patient Health Outcomes with Individualized Continuing Medical Education for Primary Care

S. Inzucchi, T. Dex, Jay Lin, 2016, Diabetes Therapy.

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status

A. Amin, Jay Lin, M. Lingohr-Smith, 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Duration of venous thromboembolism risk across a continuum in medically ill hospitalized patients.

A. Amin, S. Johnston, H. Varker, 2012, Journal of hospital medicine.

Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism

J. Benner, Jay Lin, S. Deitelzweig, 2008, Thrombosis and Haemostasis.

Evaluation of Costs Associated with Tolvaptan-Mediated Hospital Length of Stay Reduction Among US Patients with the Syndrome of Inappropriate Antidiuretic Hormone Secretion, Based on SALT-1 and SALT-2 Trials

J. Dasta, Jay Lin, J. Chiong, 2012, Hospital practice.

Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US

A. Amin, Jay Lin, S. Deitelzweig, 2019, Journal of medical economics.

Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis

A. Amin, Jay Lin, M. Lingohr-Smith, 2018, Advances in Therapy.

Inpatient and Outpatient Occurrence of Deep Vein Thrombosis and Pulmonary Embolism and Thromboprophylaxis Following Selected At-Risk Surgeries

A. Amin, Jay Lin, S. Thompson, 2011, The Annals of pharmacotherapy.

Economic Impact of Enoxaparin After Acute Ischemic Stroke Based on PREVAIL

L. Annemans, G. Pineo, Jay Lin, 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Are surgical patients at risk of venous thromboembolism currently meeting the Surgical Care Improvement Project performance measure for appropriate and timely prophylaxis?

D. Battleman, Jay Lin, S. Deitelzweig, 2010, Journal of Thrombosis and Thrombolysis.

Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis?

A. Amin, Guiping Yang, S. Stemkowski, 2009, Journal of oncology practice.

Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients.

A. Amin, Guiping Yang, S. Stemkowski, 2009, Journal of hospital medicine.

Comparison of Health Care Utilization and Costs Between Patients with Perianal Fistulizing Crohn's Disease Treated with Biologics with or Without Previous Seton Placement

S. Eichner, D. Schwartz, M. Skup, 2017, Inflammatory bowel diseases.

Retrospective Administrative Database Study of the Time Period of Venous Thromboembolism Risk During and Following Hospitalization for Major Orthopedic or Abdominal Surgery in Real-World US Patients

A. Amin, S. Johnston, G. Lenhart, 2011, Hospital practice.

134

Jay Lin, S. Deitelzweig, M. Lingohr-Smith, 2018, Critical Care Medicine.

Use of Real-World Claim Databases to Assess Prevalence of Comorbid Conditions Relevant to the Treatment of Chronic Myelogenous Leukemia Based on National Comprehensive Network Treatment Guidelines.

E. Jabbour, Jay Lin, Dinara Makenbaeva, 2015, Clinical lymphoma, myeloma & leukemia.

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States

A. Khorana, Jay Lin, M. Dalal, 2013, Cancer.

Total costs and atrial fibrillation ablation success or failure in medicare-aged patients in the United States

Jay Lin, Michael H. Kim, C. Kreilick, 2010, Advances in therapy.

Economic modeling to evaluate the impact of chronic myeloid leukemia therapy management on the oncology care model in the US

Martin F Mendiola, E. Jabbour, Jay Lin, 2019, Journal of medical economics.

Economic value of regular monitoring of response to treatment among US patients with chronic myeloid leukemia based on an economic model

E. Jabbour, Jay Lin, L. Siegartel, 2018, Journal of medical economics.

Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA

G. Fermann, Jay Lin, S. Deitelzweig, 2020, Advances in Therapy.

Cost of atrial fibrillation in United States managed care organizations

D. Battleman, Jay Lin, M. Hussein, 2009, Advances in therapy.

Cost of Hospital Admission for Antiarrhythmic Drug Initiation in Atrial Fibrillation

D. Battleman, Jay Lin, Michael H. Kim, 2009, The Annals of pharmacotherapy.

Hospital Readmissions in US Atrial Fibrillation Patients: Occurrence and Costs

A. Amin, M. Jhaveri, Jay Lin, 2013, American journal of therapeutics.

Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA

C. Russ, Jay Lin, S. Deitelzweig, 2020, Journal of medical economics.

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

C. Russ, O. Dina, Jay Lin, 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

C. Russ, O. Dina, Jay Lin, 2019, Current medical research and opinion.

Are atrial fibrillation patients receiving warfarin in accordance with stroke risk?

P. Zimetbaum, Jay Lin, P. Kothawala, 2010, The American journal of medicine.

Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy.

J. Alpert, M. Jhaveri, E. Wu, 2013, International journal of cardiology.

One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.

M. Jhaveri, Jay Lin, Michael H. Kim, 2011, Clinical therapeutics.

All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants

J. Trocio, P. Hlavacek, Jay Lin, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Economic Evaluations of Medical Cost Differences: Use of Targeted-SpecificOral Anticoagulants vs. Warfarin among Patients with Nonvalvular AtrialFibrillation and Venous Thromboembolism in the U.S.

A. Amin, J. Trocio, Jay Lin, 2015 .

Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US

A. Amin, J. Trocio, Jay Lin, 2015, Journal of medical economics.

Rates and implications for hospitalization of patients ≥65 years of age with atrial fibrillation/flutter.

S. Johnston, G. Naccarelli, Jay Lin, 2012, The American journal of cardiology.

Estimation of Potential Cost Savings Associated With Reduced Rates of Cardiovascular Hospitalization Among Atrial Fibrillation/Flutter Patients Treated With Dronedarone in the ATHENA Trial

M. Jhaveri, M. Reynolds, Jay Lin, 2014, American journal of therapeutics.

Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysis

C. Wysham, L. Kuritzky, Jay Lin, 2017, Postgraduate medicine.

Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors

A. Amin, M. Jhaveri, Jay Lin, 2012, Journal of medical economics.

Patterns and Predictors of Discontinuation of Rhythm‐Control Drug Therapy in Patients with Newly Diagnosed Atrial Fibrillation

D. Battleman, Jay Lin, Michael H. Kim, 2009, Pharmacotherapy.

Cost Burden of Cardiovascular Hospitalization and Mortality in ATHENA‐Like Patients With Atrial Fibrillation/Atrial Flutter in the United States

S. Johnston, G. Naccarelli, Jay Lin, 2010, Clinical cardiology.

Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States

G. McComsey, Jay Lin, R. Rogers, 2021, Advances in Therapy.

Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States

A. Khorana, Jay Lin, M. Dalal, 2013, ClinicoEconomics and outcomes research : CEOR.

Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States

S. Feldman, Jashin J. Wu, Jay Lin, 2018, The Journal of dermatological treatment.

Effect of Prior Biologic Use on Cost-Effectiveness of Brodalumab vs. Ustekinumab for Treatment of Moderate-to-Severe Psoriasis in the United States

S. Feldman, Jay Lin, S. Rastogi, 2018, Dermatology and Therapy.

Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with Schizophrenia

Jay Lin, S. Offord, B. Wong, 2013, Advances in Therapy.

Occurrence of Chronic Pelvic Pain, Abnormal Uterine Bleeding, and Hysterectomy Post-procedure among Women Who Have Undergone Female Sterilization Procedures: A Retrospective Claims Analysis of Commercially Insured Women in the US.

Jay Lin, A. Law, Jianying Yao, 2017, Journal of minimally invasive gynecology.

Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn’s Disease

M. Skup, J. Chao, R. Cross, 2018, Digestive Diseases and Sciences.

Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation.

J. Trocio, Jay Lin, J. Mardekian, 2017, Journal of managed care & specialty pharmacy.

A Review of Clinical Trial Endpoints of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension and How They Relate to Patient Outcomes in the United States.

S. Mathai, Jay Lin, E. Wang, 2017, Journal of managed care & specialty pharmacy.

Twelve-month discontinuation rates of levonorgestrel intrauterine system 13.5 mg and subdermal etonogestrel implant in women aged 18-44: A retrospective claims database analysis.

Jay Lin, A. Law, R. Lynen, 2018, Contraception.

Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations.

Jay Lin, Alex C Spyropoulos, Jay Lin, 2015, Journal of managed care pharmacy : JMCP.

National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry

L. Ji, S. Tsai, Jay Lin, 2015, Diabetes Therapy.

Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials

A. Amin, Jay Lin, Y. Jing, 2012, Journal of medical economics.

Hospitals' compliance with prophylaxis guidelines for venous thromboembolism.

R. Dubois, Jay Lin, M. Dylan, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH

P. Lucidi, F. Porcellati, G. Bolli, 2017, Medicine.

Temporal trend in the use of hysteroscopic vs laparoscopic sterilization and the characteristics of commercially insured and Medicaid-insured females in the US who have had the procedures

Jay Lin, A. Law, P. Carney, 2016, International journal of women's health.

Update on tolvaptan for the treatment of hyponatremia

J. Dasta, Jay Lin, J. Chiong, 2012, Expert review of pharmacoeconomics & outcomes research.

Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial

J. Dasta, Jay Lin, J. Chiong, 2012, Journal of medical economics.

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States

E. Muser, Jay Lin, K. Joshi, 2016, Journal of clinical psychopharmacology.

Healthcare Cost Reductions Associated with the Use of LAI Formulations of Antipsychotic Medications Versus Oral Among Patients with Schizophrenia

Jay Lin, S. Offord, B. Wong, 2013, The Journal of Behavioral Health Services & Research.

COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies

Jay Lin, M. M. Moran, J. Judy, 2021, medRxiv.

Appropriate thromboprophylaxis in hospitalized cancer patients.

A. Amin, Guiping Yang, S. Stemkowski, 2008, Clinical advances in hematology & oncology : H&O.

Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase

E. Jabbour, Jay Lin, L. Siegartel, 2017, Journal of medical economics.

Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors

Jay Lin, Dinara Makenbaeva, M. Lingohr-Smith, 2017, Journal of medical economics.

Health outcomes and economic burden of hospitalized COVID-19 patients in the United States

F. Angulo, B. Emir, Jay Lin, 2021, Journal of medical economics.

Hospital-based costs associated with venous thromboembolism prophylaxis regimens

D. Battleman, G. Merli, Jay Lin, 2010, Journal of Thrombosis and Thrombolysis.

Estimation of the impact of warfarin’s time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials

A. Amin, Jay Lin, Y. Jing, 2014, Journal of Thrombosis and Thrombolysis.

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients

L. Annemans, G. Pineo, Jay Lin, 2012, ClinicoEconomics and outcomes research : CEOR.

incidence of VTE in patients with acute ischemic stroke and restricted mobility , guidelines from the American College of Chest

L. Annemans, G. Pineo, Jay Lin, 2012 .

Clinical and Economic Outcomes Following Full or Partial ACCP Recommended Prophylaxis in Cancer Patients at Risk of Venous Thromboembolism

A. Amin, Guiping Yang, S. Stemkowski, 2008 .

Evaluation of incremental healthcare resource burden and readmission rates associated with hospitalized hyponatremic patients in the US.

A. Amin, Jay Lin, S. Deitelzweig, 2012, Journal of hospital medicine.

Frequency of Hospital Readmissions Post Allogeneic Hematopoietic Cell Transplantation

Jay Lin, E. Mozaffari, M. Lingohr-Smith, 2016 .

Hospitalizations and Mortality Associated with dsDNA Viral Infections Among Hematopoietic Cell Transplant Recipients

Jay Lin, E. Mozaffari, M. Lingohr-Smith, 2015 .

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States

C. Russ, O. Dina, Jay Lin, 2020, Journal of drug assessment.

Health Care Utilization, Costs, and Readmission Rates Associated With Hyponatremia

A. Amin, Jay Lin, S. Deitelzweig, 2013, Hospital practice.

Economic Burden of Treatment‐Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United States

L. Alphs, J. Sheehan, Jay Lin, 2019, Psychiatric research and clinical practice.

The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans

S. Feldman, Jashin J. Wu, Jay Lin, 2018, Journal of medical economics.

Rates of venous thromboembolism occurrence in medical patients among the insured population

D. Battleman, Jay Lin, M. Hussein, 2008, Thrombosis and Haemostasis.

Healthcare resource burden associated with hyponatremia among patients hospitalized for heart failure in the US

A. Amin, Jay Lin, S. Deitelzweig, 2013, Journal of medical economics.

Hyponatremia-Associated Healthcare Burden Among US Patients Hospitalized for Cirrhosis

A. Amin, Jay Lin, S. Deitelzweig, 2012, Advances in Therapy.

Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors

A. Amin, M. Jhaveri, Jay Lin, 2011, Advances in therapy.

Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials.

J. Rosenstock, R. Roussel, P. de Pablos-Velasco, 2014, Journal of diabetes and its complications.

Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia

S. Chase, J. Dasta, Jay Lin, 2018, Hospital practice.

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting

J. Trocio, A. Nadkarni, Jay Lin, 2017, Journal of medical economics.

Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation

J. Trocio, Jay Lin, S. Deitelzweig, 2016, Current medical research and opinion.

Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials

A. Amin, Jay Lin, Y. Jing, 2013, Journal of medical economics.

Using Health Care Claims Data to Assess the Prevalence of Hodgkin Lymphoma and Relapsed or Refractory Hodgkin Lymphoma in the United States.

Jay Lin, L. Siegartel, Dinara Makenbaeva, 2017, Clinical therapeutics.

Evaluation of hospitalization costs and associated factors among maternity stays involving low-risk and moderate- to high-risk childbirths in the United States

Jay Lin, A. Law, R. Lynen, 2017, Hospital practice.

Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients

C. Karson, B. Gutierrez, R. Baker, 2015, Drugs in context.

Impact of Warfarin Persistence on Health-Care Utilization and Costs Among Patients With Atrial Fibrillation Managed in Anticoagulation Clinics in the United States

J. Trocio, Jay Lin, S. Deitelzweig, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants

J. Trocio, Jay Lin, S. Deitelzweig, 2016, Current medical research and opinion.

Direct Medical Costs of Venous Thromboembolism and Subsequent Hospital Readmission Rates: An Administrative Claims Analysis From 30 Managed Care Organizations

Jay Lin, A. Spyropoulos, 2007, Journal of managed care pharmacy : JMCP.

Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients

J. Trocio, Jay Lin, J. Mardekian, 2017, Current medical research and opinion.

Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer.

A. Khorana, Jay Lin, M. Dalal, 2012, Lung cancer.

Hospitalization Resource Utilization and Costs Among Medicaid Insured Patients With Schizophrenia With Different Treatment Durations of Long-Acting Injectable Antipsychotic Therapy

C. Karson, Jay Lin, S. Offord, 2014, Journal of clinical psychopharmacology.

Bacterial Vaginosis Treatment Patterns, Associated Complications, and Health Care Economic Burden of Women With Medicaid Coverage in the United States

K. Tangirala, Jay Lin, K. Collins, 2023, The Annals of pharmacotherapy.

Patient profiles, initial hospital encounter characteristics, and hospital re-encounters of patients with a hospital emergency department visit or inpatient admission for major depressive disorder

M. Mathews, Jay Lin, Qiaoyi Zhang, 2022, Journal of medical economics.

Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Jay Lin, S. Deitelzweig, M. Lingohr-Smith, 2017, Journal of medical economics.

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

A. Amin, Jay Lin, Y. Jing, 2013, Cardiology and Therapy.

Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?

Jay Lin, R. Preblick, A. Spyropoulos, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

National assessment of medicare prescription plan coverage gaps among patients with atrial fibrillation in the US

Jay Lin, Michael H. Kim, C. Kreilick, 2009, Advances in therapy.

Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients.

A. Amin, Guiping Yang, S. Stemkowski, 2009, Journal of hospital medicine.

Evaluation of incremental healthcare resource burden and readmission rates associated with hospitalized hyponatremic patients in the US.

A. Amin, Jay Lin, S. Deitelzweig, 2012, Journal of hospital medicine.

Appropriate VTE Prophylaxis is Associated with Lower Direct Medical Costs

A. Amin, D. Battleman, G. Merli, 2010, Hospital practice.

Total costs and atrial fibrillation ablation success or failure in medicare-aged patients in the United States

Jay Lin, Michael H. Kim, C. Kreilick, 2010, Advances in therapy.

Clinicoeconomics and Outcomes Research Dovepress Real-world Medication Persistence and Outcomes Associated with Basal Insulin and Glucagon-like Peptide 1 Receptor Agonist Free-dose Combination Therapy in Patients with Type 2 Diabetes in the Us

T. Fan, Jay Lin, M. Lingohr-Smith, 2022 .